International expert meeting “Health Business Connect” in France

Furthering cooperation between component manufacturers and medical device manufacturers from Germany and France as well as joint projects, experience exchange and potential opportunities for cooperation are the focal points of the two-day, English-language event.

Talks, discussions and company presentations will focus on current issues regarding medical device components like diagnostic sensors, integration technology in wearables, microfluidic parts for Point-of-Care-Analytics (PoC) and Lab-on-Chip, and electronic components for integration in medical devices.

In addition, secondary topics like software requirements and digitalization will be featured.

The program is rounded out with company visits at the Temis Technology Park, on-site B2B meetings, a guided tour through Besançon and a networking event in the evening of the first conference day.

The event is aimed at medical technology companies on the entire value chain: technology developers, component manufacturers, software, test and analysis businesses and medical device manufacturers alike will find great opportunities for cooperation and networking.

Further information is available at www.ivam.com

http://www.ivam.com

Media Contact

Mona Okroy-Hellweg idw - Informationsdienst Wissenschaft

All latest news from the category: Event News

Back to home

Comments (0)

Write a comment

Newest articles

Urban stormwater detention basin affected by salt pollution and salt-tolerant plants

Going Green: Fighting Freshwater Salt Pollution with Phytoremediation

Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often…

Illustration of leaky gut and inflammation in psoriasis research

Psoriasis Patients at Increased Risk for Crohn’s Due to Gut Inflammation

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new research at Uppsala University. These changes…

Vials of GLP-1 receptor agonist drugs illustrating benefits and potential risks

Popular Weight-Loss Drugs—Beneficial or Risky?

GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems Growing Public Demand for GLP-1RA Weight-Loss Medications Demand for weight-loss medications sold under…